1. Home
  2. Labeler Index
  3. Buddate Co Ltd
  4. NDC Product Code: 71173-3000 Buddate Reges Intensive Treatment

NDC 71173-3000 Buddate Reges Intensive Treatment

Butylene Glycol,Hydrogenated Coconut Oil,Butyrospermum Parkii (shea) Butter,Palmitoyl - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 71173-3000?
  4. Buddate Reges Intensive Treatment Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes

Product Information

NDC Product Code:
71173-3000
Proprietary Name:
Buddate Reges Intensive Treatment
Non-Proprietary Name: [1]
Butylene Glycol, Hydrogenated Coconut Oil, Butyrospermum Parkii (shea) Butter, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7
Substance Name: [2]
Butylene Glycol; Hydrogenated Coconut Oil; Palmitoyl Tetrapeptide-7; Palmitoyl Tripeptide-1; Shea Butter
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route(s): [4]
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
    • Labeler Name: [5]
    Buddate Co Ltd
    Labeler Code:
    71173
    Product Label ID:
    46495321-fb14-3479-e054-00144ff88e88
    Marketing Category: [8]
    UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
    Start Marketing Date: [9]
    01-01-2017
    Listing Expiration Date: [11]
    12-31-2024
    Exclude Flag: [12]
    N
    Code Navigator:

    Code Structure Chart

    Product Details

    What is NDC 71173-3000?

    The NDC code 71173-3000 is assigned by the FDA to the product Buddate Reges Intensive Treatment which is a human over the counter drug product labeled by Buddate Co Ltd. The generic name of Buddate Reges Intensive Treatment is butylene glycol, hydrogenated coconut oil, butyrospermum parkii (shea) butter, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7. The product's dosage form is cream and is administered via topical form. The product is distributed in a single package with assigned NDC code 71173-3000-1 70 ml in 1 tube . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Buddate Reges Intensive Treatment?

    Apply a generous amount of the cream three times a day to your body needing to be nourishd, and then softly massage your skin.

    What are Buddate Reges Intensive Treatment Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    Which are Buddate Reges Intensive Treatment UNII Codes?

    The UNII codes for the active ingredients in this product are:

    Which are Buddate Reges Intensive Treatment Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".